GAMCO Investors’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-60,000
Closed -$240K 1047
2025
Q2
$240K Buy
+60,000
New +$149K ﹤0.01% 980

GAMCO Investors's INZY Position: Q3 2025 in Review

GAMCO Investors sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 60,000 shares — an estimated $240K sold.

GAMCO Investors first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $240K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • GAMCO Investors reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • GAMCO Investors sold 60,000 Inozyme Pharma shares in Q3 2025, an estimated $240K.
  • GAMCO Investors first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
  • GAMCO Investors's Inozyme Pharma position peaked at $240K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on GAMCO Investors's 13F filing for Q3 2025, filed 12 Nov 2025.